IMVT Insider Transactions
| Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2023-02-02 | Macias William L. | officer: Chief Medical Officer | 262,996 | S-Sale | D | 537 | 18.24 | 9,794.88 |
| 2023-01-26 | Levine Mark S. | officer: Chief Legal Officer | 245,660 | S-Sale | D | 10,156 | 18.51 | 187,987.56 |
| 2023-01-11 | Salzmann Peter | director, officer: Chief Executive Officer | 993,932 | S-Sale | D | 4,021 | 16.80 | 67,552.80 |
| 2023-01-11 | Barnett Eva Renee | officer: Chief Financial Officer | 268,347 | S-Sale | D | 4,499 | 16.75 | 75,358.25 |
| 2023-01-11 | Barnett Eva Renee | officer: Chief Financial Officer | 272,846 | S-Sale | D | 11 | 15.15 | 166.65 |
| 2023-01-11 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 331,419 | S-Sale | D | 60,471 | 16.79 | 1,015,308.09 |
| 2023-01-11 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 391,890 | S-Sale | D | 19 | 15.16 | 288.04 |
| 2023-01-11 | Macias William L. | officer: Chief Medical Officer | 263,533 | S-Sale | D | 44,448 | 16.75 | 744,504.00 |
| 2023-01-11 | Macias William L. | officer: Chief Medical Officer | 307,981 | S-Sale | D | 120 | 15.11 | 1,813.20 |
| 2022-10-21 | Macias William L. | officer: Chief Medical Officer | 308,101 | S-Sale | D | 341 | 9.67 | 3,297.47 |
| 2022-10-13 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 391,909 | S-Sale | D | 928 | 9.18 | 8,519.04 |
| 2022-10-13 | Salzmann Peter | director, officer: Chief Executive Officer | 997,953 | S-Sale | D | 2,793 | 9.18 | 25,639.74 |
| 2022-10-11 | Barnett Eva Renee | officer: Chief Financial Officer | 272,857 | S-Sale | D | 12,500 | 9.44 | 118,000.00 |
| 2022-10-06 | Roivant Sciences Ltd. | 10 percent owner | 73,805,331 | P-Purchase | A | 416,667 | 6.00 | 2,500,002.00 |
| 2022-09-30 | Pande Atul | director | 20,000 | P-Purchase | A | 15,000 | 5.60 | 84,000.00 |
| 2022-09-29 | Torti Frank | director | 393,358 | P-Purchase | A | 20,000 | 5.81 | 116,200.00 |
| 2022-09-28 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 392,837 | S-Sale | D | 535 | 4.67 | 2,498.45 |
| 2022-09-28 | Salzmann Peter | director, officer: Chief Executive Officer | 1,000,746 | S-Sale | D | 1,605 | 4.67 | 7,495.35 |
| 2022-08-30 | Salzmann Peter | director, officer: Chief Executive Officer | 1,002,351 | S-Sale | D | 1,644 | 5.83 | 9,584.52 |
| 2022-08-30 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 393,372 | S-Sale | D | 548 | 5.83 | 3,194.84 |
| 2022-08-17 | Levine Mark S. | officer: Chief Legal Officer | 169,648 | A-Award | A | 169,648 | 4.99 | 846,543.52 |
| 2022-08-17 | Levine Mark S. | officer: Chief Legal Officer | 255,816 | A-Award | A | 112,816 | 0.00 | 0.00 |
| 2022-08-17 | Macias William L. | officer: Chief Medical Officer | 169,648 | A-Award | A | 169,648 | 4.99 | 846,543.52 |
| 2022-08-17 | Macias William L. | officer: Chief Medical Officer | 308,442 | A-Award | A | 112,816 | 0.00 | 0.00 |
| 2022-08-17 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 169,648 | A-Award | A | 169,648 | 4.99 | 846,543.52 |
| 2022-08-17 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 393,920 | A-Award | A | 112,816 | 0.00 | 0.00 |
| 2022-08-17 | Salzmann Peter | director, officer: Chief Executive Officer | 678,592 | A-Award | A | 678,592 | 4.99 | 3,386,174.08 |
| 2022-08-17 | Salzmann Peter | director, officer: Chief Executive Officer | 1,003,995 | A-Award | A | 451,264 | 0.00 | 0.00 |
| 2022-08-17 | Barnett Eva Renee | officer: Chief Financial Officer | 169,648 | A-Award | A | 169,648 | 4.99 | 846,543.52 |
| 2022-08-17 | Barnett Eva Renee | officer: Chief Financial Officer | 285,357 | A-Award | A | 112,816 | 0.00 | 0.00 |
| 2022-08-17 | Fromkin Andrew J. | director | 31,668 | A-Award | A | 31,668 | 4.99 | 158,023.32 |
| 2022-08-17 | Fromkin Andrew J. | director | 88,485 | A-Award | A | 21,059 | 0.00 | 0.00 |
| 2022-08-17 | MIGAUSKY GEORGE V | director | 31,668 | A-Award | A | 31,668 | 4.99 | 158,023.32 |
| 2022-08-17 | MIGAUSKY GEORGE V | director | 109,985 | A-Award | A | 21,059 | 0.00 | 0.00 |
| 2022-08-17 | Pande Atul | director | 31,668 | A-Award | A | 31,668 | 4.99 | 158,023.32 |
| 2022-08-17 | Pande Atul | director | 82,985 | A-Award | A | 21,059 | 0.00 | 0.00 |
| 2022-08-17 | Torti Frank | director | 339,296 | A-Award | A | 339,296 | 4.99 | 1,693,087.04 |
| 2022-08-17 | Torti Frank | director | 373,358 | A-Award | A | 225,632 | 0.00 | 0.00 |
| 2022-08-17 | Hughes Douglas J. | director | 31,668 | A-Award | A | 31,668 | 4.99 | 158,023.32 |
| 2022-08-17 | Hughes Douglas J. | director | 101,232 | A-Award | A | 21,059 | 0.00 | 0.00 |
| 2022-07-27 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 281,104 | S-Sale | D | 510 | 4.27 | 2,177.70 |
| 2022-07-27 | Salzmann Peter | director, officer: Chief Executive Officer | 552,731 | S-Sale | D | 1,528 | 4.27 | 6,524.56 |
| 2022-07-22 | Macias William L. | officer: Chief Medical Officer | 195,626 | S-Sale | D | 322 | 4.70 | 1,513.40 |
| 2022-06-29 | Salzmann Peter | director, officer: Chief Executive Officer | 554,259 | S-Sale | D | 1,376 | 4.02 | 5,531.52 |
| 2022-06-29 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 281,614 | S-Sale | D | 460 | 4.02 | 1,849.20 |
| 2022-05-24 | Salzmann Peter | director, officer: Chief Executive Officer | 555,635 | S-Sale | D | 1,471 | 3.79 | 5,575.09 |
| 2022-05-24 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 282,074 | S-Sale | D | 492 | 3.79 | 1,864.68 |
| 2022-04-27 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 282,566 | S-Sale | D | 541 | 4.72 | 2,553.52 |
| 2022-04-27 | Salzmann Peter | director, officer: Chief Executive Officer | 557,106 | S-Sale | D | 1,622 | 4.72 | 7,655.84 |
| 2022-04-19 | Macias William L. | officer: Chief Medical Officer | 195,948 | S-Sale | D | 1,392 | 4.98 | 6,932.16 |
| 2022-03-24 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 283,107 | S-Sale | D | 6,381 | 5.90 | 37,647.90 |
| 2022-03-24 | Salzmann Peter | director, officer: Chief Executive Officer | 558,728 | S-Sale | D | 19,227 | 5.90 | 113,439.30 |
| 2022-01-28 | Levine Mark S. | officer: Chief Legal Officer | 383,000 | A-Award | A | 383,000 | 6.72 | 2,573,760.00 |
| 2022-01-28 | Levine Mark S. | officer: Chief Legal Officer | 143,000 | A-Award | A | 143,000 | 0.00 | 0.00 |
| 2022-01-10 | Torti Frank | director | 554,748 | A-Award | A | 329,485 | 7.94 | 2,616,110.90 |
| 2022-01-10 | Torti Frank | director | 147,726 | A-Award | A | 100,126 | 0.00 | 0.00 |
| 2022-01-10 | Fromkin Andrew J. | director | 208,973 | A-Award | A | 71,492 | 7.94 | 567,646.48 |
| 2022-01-10 | Fromkin Andrew J. | director | 67,426 | A-Award | A | 21,726 | 0.00 | 0.00 |
| 2022-01-10 | MIGAUSKY GEORGE V | director | 131,792 | A-Award | A | 71,492 | 7.94 | 567,646.48 |
| 2022-01-10 | MIGAUSKY GEORGE V | director | 88,926 | A-Award | A | 21,726 | 0.00 | 0.00 |
| 2022-01-10 | Hughes Douglas J. | director | 208,973 | A-Award | A | 71,492 | 7.94 | 567,646.48 |
| 2022-01-10 | Hughes Douglas J. | director | 80,173 | A-Award | A | 21,726 | 0.00 | 0.00 |
| 2022-01-10 | Pande Atul | director | 208,973 | A-Award | A | 71,492 | 7.94 | 567,646.48 |
| 2022-01-10 | Pande Atul | director | 61,926 | A-Award | A | 21,726 | 0.00 | 0.00 |
| 2022-01-07 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 289,488 | S-Sale | D | 55,318 | 7.25 | 401,055.50 |
| 2022-01-07 | Barnett Eva Renee | officer: Chief Financial Officer | 172,541 | S-Sale | D | 29,959 | 7.25 | 217,202.75 |
| 2022-01-07 | Salzmann Peter | director, officer: Chief Executive Officer | 577,955 | S-Sale | D | 125,158 | 7.25 | 907,395.50 |
| 2022-01-05 | Macias William L. | officer: Chief Medical Officer | 197,340 | S-Sale | D | 26,813 | 8.28 | 222,011.64 |
| 2021-11-05 | Macias William L. | officer: Chief Medical Officer | 167,325 | A-Award | A | 167,325 | 8.58 | 1,435,648.50 |
| 2021-11-05 | Macias William L. | officer: Chief Medical Officer | 224,153 | A-Award | A | 112,108 | 0.00 | 0.00 |
| 2021-10-15 | Barnett Eva Renee | officer: Chief Financial Officer | 333,000 | A-Award | A | 333,000 | 8.72 | 2,903,760.00 |
| 2021-10-15 | Barnett Eva Renee | officer: Chief Financial Officer | 202,500 | A-Award | A | 143,000 | 0.00 | 0.00 |
| 2021-10-04 | Barnett Eva Renee | officer: Chief Financial Officer | 59,500 | A-Award | A | 59,500 | 0.00 | 0.00 |
| 2021-09-11 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 319,700 | A-Award | A | 319,700 | 8.62 | 2,755,814.00 |
| 2021-09-11 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 0 | D-Return | D | 319,700 | 8.62 | 2,755,814.00 |
| 2021-09-11 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 191,100 | A-Award | A | 191,100 | 8.62 | 1,647,282.00 |
| 2021-09-11 | Salzmann Peter | director, officer: Chief Executive Officer | 464,700 | A-Award | A | 464,700 | 8.62 | 4,005,714.00 |
| 2021-09-11 | Salzmann Peter | director, officer: Chief Executive Officer | 430,700 | A-Award | A | 430,700 | 8.62 | 3,712,634.00 |
| 2021-09-11 | Salzmann Peter | director, officer: Chief Executive Officer | 0 | D-Return | D | 430,700 | 8.62 | 3,712,634.00 |
| 2021-09-11 | Macias William L. | officer: Chief Medical Officer | 369,320 | A-Award | A | 369,320 | 8.62 | 3,183,538.40 |
| 2021-09-11 | Macias William L. | officer: Chief Medical Officer | 0 | D-Return | D | 369,320 | 8.62 | 3,183,538.40 |
| 2021-08-27 | Hughes Douglas J. | director | 58,447 | P-Purchase | A | 18,247 | 8.24 | 150,355.28 |
| 2021-08-20 | MIGAUSKY GEORGE V | director | 67,200 | P-Purchase | A | 7,000 | 7.65 | 53,550.00 |
| 2021-08-13 | Pande Atul | director | 45,200 | P-Purchase | A | 5,000 | 7.98 | 39,900.00 |
| 2021-08-10 | Fromkin Andrew J. | director | 45,700 | P-Purchase | A | 5,500 | 7.90 | 43,450.00 |
| 2021-08-03 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 344,806 | A-Award | A | 285,306 | 0.00 | 0.00 |
| 2021-08-03 | Salzmann Peter | director, officer: Chief Executive Officer | 703,113 | A-Award | A | 570,613 | 0.00 | 0.00 |
| 2021-08-02 | Roivant Sciences Ltd. | 10 percent owner | 73,388,664 | J-Other | A | 17,021,276 | 0.00 | 0.00 |
| 2021-06-11 | Macias William L. | officer: Chief Medical Officer | 18,674 | A-Award | A | 18,674 | 10.71 | 199,998.54 |
| 2021-06-11 | Macias William L. | officer: Chief Medical Officer | 112,045 | A-Award | A | 93,371 | 0.00 | 0.00 |
| 2021-06-11 | Macias William L. | officer: Chief Medical Officer | 369,320 | A-Award | A | 369,320 | 10.71 | 3,955,417.20 |
| 2021-03-19 | MIGAUSKY GEORGE V | director | 60,200 | A-Award | A | 15,500 | 0.00 | 0.00 |
| 2021-03-19 | MIGAUSKY GEORGE V | director | 23,300 | A-Award | A | 23,300 | 17.00 | 396,100.00 |
| 2021-03-19 | Torti Frank | director | 28,900 | A-Award | A | 28,900 | 17.00 | 491,300.00 |
| 2021-03-19 | Torti Frank | director | 47,600 | A-Award | A | 19,200 | 0.00 | 0.00 |
| 2021-03-19 | Elliott Michael James | officer: Chief Scientific Officer | 97,600 | A-Award | A | 97,600 | 0.00 | 0.00 |
| 2021-03-19 | Elliott Michael James | officer: Chief Scientific Officer | 342,300 | A-Award | A | 342,300 | 17.00 | 5,819,100.00 |
| 2021-03-19 | Hughes Douglas J. | director | 40,200 | A-Award | A | 15,500 | 0.00 | 0.00 |
| 2021-03-19 | Hughes Douglas J. | director | 23,300 | A-Award | A | 23,300 | 17.00 | 396,100.00 |
| 2021-03-19 | Butchko Julia G. | officer: Chief Dev. & Tech. Officer | 191,100 | A-Award | A | 191,100 | 17.00 | 3,248,700.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.